<?xml version="1.0" encoding="UTF-8"?>
<p>The survey was conducted in May 2020, and therefore it was issued more than one month after the UK government's 'Stay Home' directive [
 <xref rid="REF8" ref-type="bibr">8</xref>]. Whilst the timing of the survey would have allowed trials to respond to the COVID-19 crisis, it may have fallen at a time where trial managers, chief investigators and sponsors were busy preparing trials to restart activity in light of the gradual easing of restrictions nationwide. The survey did not explore the process or timeline of the response to the pandemic. Some CTUs, sponsors and trials may have adapted and prepared in advance of the WHO declaration of SARS-nCOV2 outbreaks as a pandemic on March 11, 2020 [
 <xref rid="REF10" ref-type="bibr">10</xref>] or the government restriction announced on March 16, 2020 [
 <xref rid="REF8" ref-type="bibr">8</xref>]. For example, the surveys asked about the mention of a pandemic on risk assessments before January 2020 only; that is mentions which preceded the WHO declaring COVID-19 a public health emergency of international concern (PHEIC) [
 <xref rid="REF10" ref-type="bibr">10</xref>].
</p>
